Literature DB >> 6960080

The risk of bleeding after percutaneous liver biopsy: relation to platelet count.

P Sharma, G B McDonald, M Banaji.   

Abstract

We sought to define the risk of bleeding after percutaneous aspiration liver biopsy in patients with low platelet counts but otherwise normal clotting factors. Eighty-seven patients underwent liver biopsy using the Menghini 1-second technique with either a 1.6-mm or a 1.2-mm needle. Bleeding occurred in three out of 13 patients whose platelet counts at the time of biopsy were 60,000/mm3 or less, as compared to no bleeding in 74 patients with higher platelet counts (p = 0.003). A liver biopsy should not necessarily be withheld because of low platelet counts unless they are below 60,000/mm3 and cannot be raised for an adequate time during and after biopsy.

Entities:  

Mesh:

Year:  1982        PMID: 6960080     DOI: 10.1097/00004836-198210000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  21 in total

1.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Acute pancreatitis secondary to hemobilia after percutaneous liver biopsy.

Authors:  Luis R Peña; Todd L Horn; Christopher B Cross
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

3.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

4.  Biopsy of the transplanted kidney.

Authors:  Iftikhar Ahmad
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

Review 5.  Haemostatic problems in liver disease.

Authors:  D A Kelly; E G Tuddenham
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

6.  Liver biopsies in patients with lysosomal storage disease: experience with effective sedation.

Authors:  R P Grewal; K T Yu; N W Barton; R I Parker; A M Bisceglie
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

7.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

8.  Plugged liver biopsy in patients with impaired coagulation.

Authors:  M V Tobin; I T Gilmore
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

9.  Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience.

Authors:  V Takyar; O Etzion; T Heller; D E Kleiner; Y Rotman; M G Ghany; N Fryzek; V H Williams; E Rivera; S Auh; T J Liang; J H Hoofnagle; C Koh
Journal:  Aliment Pharmacol Ther       Date:  2017-01-10       Impact factor: 8.171

10.  Blind and ultrasound-guided percutaneous liver biopsy in children.

Authors:  Valerio Nobili; Donatella Comparcola; Maria Rita Sartorelli; Gianluigi Natali; Lidia Monti; Piergiorgio Falappa; Matilde Marcellini
Journal:  Pediatr Radiol       Date:  2003-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.